Formula One (F1) has renewed its contract with Circuit de Barcelona-Catalunya, assuring that the Spanish Grand Prix will be on its calendar until 2026.
The Spanish Grand Prix has been part of the circuit since 1991 and runs its preseason testing at the venue.
The extended agreement specifies that improvements to the track and its facilities will be made ahead of the 2022 race, including an advancement on the circuit’s sustainability plans.
Last month, F1 confirmed that next year’s Spanish Grand Prix would occur on 22nd May.
According to F1 CEO Stefano Domenicali, with improvements to the track and facilities, they would continue their long history of holding races in Barcelona.
Circuit de Barcelona-Catalunya also secured a deal with Dorna Sports, manager of global motorcycling championship MotoGP, to extend that series’ presence at the venue for another five years.


Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Why the Australian Open’s online tennis coverage looks like a Wii sports game
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
Samsung Electronics Shares Jump on HBM4 Mass Production Report
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
Nikkei 225 Hits Record High Above 56,000 After Japan Election Boosts Market Confidence
Gold and Silver Prices Climb in Asian Trade as Markets Eye Key U.S. Economic Data
Asian Markets Surge as Japan Election, Fed Rate Cut Bets, and Tech Rally Lift Global Sentiment
Extreme heat, flooding, wildfires – Colorado’s formerly incarcerated people on the hazards they faced behind bars
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
NBA Returns to China with Alibaba Partnership and Historic Macau Games
Trump Plans UFC Event at White House for America’s 250th Anniversary
Trump Signs Executive Order Targeting Big-Money College Athlete Payouts
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



